乳蛋白水解物市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

2024 年全球乳蛋白水解物市场价值为 21 亿美元，预计到 2034 年将以 6.7% 的复合年增长率增长至 59 亿美元。

乳蛋白水解物是一类先进的生物活性成分，透过对牛奶蛋白进行严格控制的酶解而製成。与完整蛋白质相比，这些蛋白质具有更高的消化率、生物利用度和更低的致敏性，使其成为运动营养、婴幼儿营养和医疗营养等营养相关行业的重要成分。水解过程将大分子蛋白质分解成更小的胜肽和胺基酸，从而加快人体吸收和利用。随着人们对功能性营养和个人化营养的日益关注，製造商正在将乳蛋白水解物应用于产品中，以满足特定的饮食和健康需求。婴幼儿营养品是最大的消费群，占全球需求的近38%。水解带来的低分子量和更高的消化率使这些蛋白质成为配製特殊营养产品的理想选择。严格的品质和安全标准持续推动市场对具有稳定功能和精确水解特性的高品质乳蛋白水解物的需求。先进的酶解技术正在革新生产方法，使製造商能够更好地控制肽谱和蛋白质结构。

2024年，乳清蛋白水解物市场营收达14亿美元，预计2025年至2034年将以6.5%的复合年增长率成长，2024年市占率将达到68%。乳清蛋白水解物以其完整的胺基酸组成、快速吸收和优异的溶解性，持续引领市场。其卓越的营养特性和加工灵活性使其适用于各种对生物利用度和功能性要求极高的产品配方。这些优势巩固了在需要高品质蛋白质来源和高效营养输送的应用领域的领先地位。

2024年，部分水解物市场规模达到9.66亿美元，预计2025年至2034年间将以6.6%的复合年增长率成长。其受欢迎程度源自于透过可控酶水解所实现的功能性益处与感官品质之间的平衡。部分水解物具有最佳的胜肽分布和蛋白质完整性，同时最大限度地降低了苦味，使其成为功能性食品、运动营养和一般饮食应用的理想选择。其良好的口感和强大的营养特性使其在多个终端应用领域中保持持续的需求。

预计2025年至2034年间，北美乳蛋白水解物市场将以6.5%的复合年增长率成长。消费者对功能性和个人化营养的日益关注正在推动区域需求，尤其是在临床、运动和婴幼儿营养等特殊蛋白质应用领域。此外，人们对消化健康和食物过敏的日益重视也加速了向先进蛋白质水解技术的转变，製造商致力于用更易消化、低致敏性的替代品取代传统蛋白质成分。

全球乳蛋白水解物市场的主要企业包括：格兰比亚营养品公司 (Glanbia Nutritionals)、菲仕兰坎皮纳配料公司 (FrieslandCampina Ingredients)、阿拉食品配料公司 (Arla Foods Ingredients)、恆天然/NZMP、凯瑞集团 (Kerry Group)、拉克塔伯里公司 (Lactalis)、卡恆天然组 (Lactalis） Group)、阿格普尔合作社 (Agropur Cooperative)、希尔玛配料公司 (Hilmar Ingredients)、牛奶特种产品全球/阿克图斯营养公司 (Milk Specialties Global/Actus Nutrition)、英格瑞亚公司 (Ingredia)、阿莫尔蛋白公司 (Armor Proteines)、AMCO蛋白公司 (AMCOteins)、Costm. Co-operative)、DMK集团/wheyco和萨普托配料公司 (Saputo Ingredients)。这些企业正积极推行以创新、合作和产能扩张为核心的策略倡议，以增强自身的竞争力。许多企业正大力投资研发，以开发具有特定胜肽谱和更佳感官特性的客製化水解物配方。与食品和营养品牌的策略合作有助于企业拓展市场，并加速先进蛋白原料的商业化进程。此外，各企业也透过新一代酵素技术和永续加工实践来提高生产效率，以满足全球品质和安全标准。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
  • 供应商格局
  • 利润率
  • 每个阶段的价值增加
  • 影响价值链的因素
  • 中断
• 产业影响因素
  • 司机
  • 陷阱与挑战
  • 机会
• 成长潜力分析
• 监管环境
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 波特的分析
• PESTEL 分析
• 价格趋势
  • 按地区
  • 按类型
• 未来市场趋势
• 技术与创新格局
  • 当前技术趋势
  • 新兴技术
• 专利格局
• 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
  • 主要进口国
  • 主要出口国
• 永续性和环境方面
  • 永续实践
  • 减少废弃物策略
  • 生产中的能源效率
  • 环保倡议
• 碳足迹考量

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • MEA
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 合作伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依类型划分，2021-2034年

• 主要趋势
• 乳清蛋白水解物
• 酪蛋白水解物
• 混合乳蛋白水解物

第六章：市场估算与预测：依水解度划分，2021-2034年

• 主要趋势
• 部分水解产物（DH 2-15%）
• 深度水解产物（DH >15%）
• 高度水解产物（DH >95%）

第七章：市场估计与预测：依形式划分，2021-2034年

• 主要趋势
• 粉状
• 贴上形式
• 液体浓缩物

第八章：市场估算与预测：依应用领域划分，2021-2034年

• 主要趋势
• 婴儿营养
  • 深度水解配方（eHF）
  • 部分水解配方（pHF）
  • 胺基酸配方（AAF）
  • 其他（后续婴儿食品、成长型婴儿食品及特殊医学用途婴儿食品）
• 运动营养
  • 运动前补充剂
  • 运动后及恢復补充剂
  • 蛋白质粉和即饮饮料
  • 其他（能量棒、固体产品和精英运动员营养品）
• 临床营养
  • 肠内营养（管饲）
  • 肠外营养（静脉输注）
  • 特殊医学用途食品与疾病特异性配方
  • 其他（营养不良、重症监护和伤口恢復）
• 动物营养
  • 乳牛饲料
  • 家禽饲料
  • 水产饲料（鱼虾营养）
  • 其他（猪、宠物食品和特殊动物营养）
• 生物技术与细胞培养基
  • 细胞培养基补充剂（血清替代品）
  • 生物加工应用（蛋白质和细胞生产）
  • 药品生产（疫苗和生物製品）
  • 其他（研究、再生医学和分析测试）

第九章：市场估计与预测：依地区划分，2021-2034年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第十章：公司简介

• Arla Foods Ingredients
• FrieslandCampina Ingredients
• Kerry Group
• Fonterra/NZMP
• Glanbia Nutritionals
• Nestle Health Science
• Lactalis Ingredients
• Carbery Group
• Milk Specialties Global/Actus Nutrition
• Agropur Cooperative
• Hilmar Ingredients
• Ingredia
• AMCO Proteins
• Armor Proteines
• Tatua Co-operative

The Global Dairy Protein Hydrolysates Market was valued at USD 2.1 billion in 2024 and is estimated to grow at a CAGR of 6.7% to reach USD 5.9 billion by 2034.

Dairy protein hydrolysates represent an advanced class of bioactive ingredients produced through carefully controlled enzymatic hydrolysis of milk proteins. These proteins are recognized for their enhanced digestibility, high bioavailability, and reduced allergenic potential compared to intact proteins, making them valuable components in nutrition-focused industries such as sports, infant, and medical nutrition. Through the hydrolysis process, large protein molecules are broken into smaller peptides and amino acids, allowing for faster absorption and efficient utilization by the body. With increasing interest in functional and personalized nutrition, manufacturers are incorporating dairy protein hydrolysates to meet targeted dietary and health needs. The infant nutrition category represents the largest consumer segment, accounting for nearly 38% of global demand. The lower molecular weight and improved digestibility achieved through hydrolysis make these proteins particularly desirable for formulating specialized nutrition products. Stringent quality and safety standards continue to drive demand for high-grade dairy protein hydrolysates with consistent functional performance and precise hydrolysis characteristics. Advanced enzymatic technologies are transforming production methods, enabling manufacturers to better control peptide profiles and protein structure.

The whey protein hydrolysates segment generated USD 1.4 billion in revenue in 2024 and is forecasted to grow at a CAGR of 6.5% from 2025 to 2034, holding a 68% share in 2024. Whey protein hydrolysates continue to lead the market due to their complete amino acid composition, rapid absorption, and exceptional solubility. Their superior nutritional properties and processing versatility make them suitable for various product formulations where bioavailability and functionality are crucial. These advantages reinforce their dominance in applications that require high-quality protein sources and efficient nutrient delivery.

The partial hydrolysates segment generated USD 966 million in 2024 and is expected to grow at a CAGR of 6.6% during 2025-2034. Their popularity lies in the balance between functional benefits and sensory qualities achieved through controlled enzymatic hydrolysis. Partial hydrolysates exhibit optimal peptide distribution and preserved protein integrity while minimizing bitterness, making them ideal for use in functional foods, sports nutrition, and general dietary applications. Their favorable taste profile and strong nutritional characteristics contribute to consistent demand across multiple end-use categories.

North America Dairy Protein Hydrolysates Market is projected to grow at a CAGR of 6.5% between 2025 and 2034. Growing consumer awareness of functional and personalized nutrition is shaping regional demand, particularly across specialized protein applications in clinical, sports, and infant nutrition. Rising attention to digestive health and food allergies is also accelerating the shift toward advanced protein hydrolysis technologies as manufacturers aim to replace traditional protein ingredients with more digestible, hypoallergenic alternatives.

Key companies operating in the Global Dairy Protein Hydrolysates Market include Glanbia Nutritionals, FrieslandCampina Ingredients, Arla Foods Ingredients, Fonterra/NZMP, Kerry Group, Lactalis Ingredients, Nestle Health Science, Carbery Group, Agropur Cooperative, Hilmar Ingredients, Milk Specialties Global/Actus Nutrition, Ingredia, Armor Proteines, AMCO Proteins, Costantino & C. spa, Tatua Co-operative, DMK Group/wheyco, and Saputo Ingredients. Companies active in the Dairy Protein Hydrolysates Market are pursuing strategic initiatives centered on innovation, partnerships, and capacity expansion to strengthen their competitive standing. Many are investing heavily in research and development to create customized hydrolysate formulations with specific peptide profiles and improved sensory characteristics. Strategic collaborations with food and nutrition brands are enabling broader market access and faster commercialization of advanced protein ingredients. Firms are also enhancing production efficiency through next-generation enzymatic technologies and sustainable processing practices to meet global quality and safety standards.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Type trends
  • 2.2.2 Degree of hydrolysis trends
  • 2.2.3 Form trends
  • 2.2.4 Application trends
  • 2.2.5 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Drivers
  • 3.2.2 Pitfalls & Challenges
  • 3.2.3 Opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By type
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Type, 2021-2034 (USD Million & Kilo Tons)

• 5.1 Key trends
• 5.2 Whey protein hydrolysates
• 5.3 Casein hydrolysates
• 5.4 Mixed milk protein hydrolysates

Chapter 6 Market Estimates and Forecast, By Degree of Hydrolysis, 2021-2034 (USD Million & Kilo Tons)

• 6.1 Key trends
• 6.2 Partial hydrolysates (DH 2-15%)
• 6.3 Extensive hydrolysates (DH >15%)
• 6.4 Highly hydrolyzed products (DH >95%)

Chapter 7 Market Estimates and Forecast, By Form, 2021-2034 (USD Million & Kilo Tons)

• 7.1 Key trends
• 7.2 Powder form
• 7.3 Paste form
• 7.4 Liquid concentrates

Chapter 8 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

• 8.1 Key trends
• 8.2 Infant nutrition
  • 8.2.1 Extensively hydrolyzed formulas (eHF)
  • 8.2.2 Partially hydrolyzed formulas (pHF)
  • 8.2.3 Amino acid-based formulas (AAF)
  • 8.2.4 Others (follow-on, growing-up, and special medical purpose infant foods)
• 8.3 Sports nutrition
  • 8.3.1 Pre-workout supplements
  • 8.3.2 Post-workout & recovery supplements
  • 8.3.3 Protein powders & RTD beverages
  • 8.3.4 Others (bars, solid form products, and elite athlete nutrition)
• 8.4 Clinical nutrition
  • 8.4.1 Enteral nutrition (tube feeding)
  • 8.4.2 Parenteral nutrition (IV administration)
  • 8.4.3 Medical foods & disease-specific formulations
  • 8.4.4 Others (malnutrition, critical care, and wound recovery)
• 8.5 Animal nutrition
  • 8.5.1 Dairy cattle feed
  • 8.5.2 Poultry feed
  • 8.5.3 Aquafeed (fish & shrimp nutrition)
  • 8.5.4 Others (swine, pet food, and specialty animal nutrition)
• 8.6 Biotechnology & cell culture media
  • 8.6.1 Cell culture media supplements (serum replacements)
  • 8.6.2 Bioprocessing applications (protein & cell production)
  • 8.6.3 Pharmaceutical manufacturing (vaccines & biologics)
  • 8.6.4 Others (research, regenerative medicine, and analytical testing)

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Arla Foods Ingredients
• 10.2 FrieslandCampina Ingredients
• 10.3 Kerry Group
• 10.4 Fonterra/NZMP
• 10.5 Glanbia Nutritionals
• 10.6 Nestle Health Science
• 10.7 Lactalis Ingredients
• 10.8 Carbery Group
• 10.9 Milk Specialties Global/Actus Nutrition
• 10.10 Agropur Cooperative
• 10.11 Hilmar Ingredients
• 10.12 Ingredia
• 10.13 AMCO Proteins
• 10.14 Armor Proteines
• 10.15 Tatua Co-operative